If thinning began immediately after starting the drug, look for: illness stress postpartum recovery crash dieting thyroid shifts medication changes These often overlap and confuse the picture
For weekly injectable semaglutide, withhold one week prior to surgery in high-risk elective cases
Retatrutide adds GIP and glucagon receptor activation, resulting in substantially greater weight loss in clinical trials
Integer et est tellus non bibendum est
Both studies were conducted in accordance with Good Clinical Practice, the Declaration of Helsinki and US Food and Drug Administration/European Medicines Agency guidelines for studies in people with renal or hepatic impairment [12,13,14,15]
Your provider will determine whether switching makes clinical sense and, if approved, establish a transition timeline that minimizes metabolic disruption